22 November 2023 INVION ACHIEVES MAJOR MILESTONE TOWARDS CLINICAL TRIALS WITH SUCCESSFUL MANUFACTURING OF INV043 UNDER GMP STANDARDS 0 minute read Pharma/Biotech By Cate Swannell Previous Post Next Post